BRIEF-Visiox 製薬のs To Be 名簿（に載せる）／表（にあげる）d On Nasdaq 経由で A 商売／仕事 Combination With PowerUp 取得／買収
Dec 27 (Reuters) - PowerUp 取得／買収 Corp:
* VISIOX PHARMACEUTICALS, INC., A COMMERCIAL-STAGE BIOPHARMACEUTICAL COMPANY TO BE LISTED ON NASDAQ THROUGH A BUSINESS COMBINATION WITH POWERUP ACQUISITION CORP.
* POWERUP ACQUISITION -EXECUTION OF DEFINITIVE AGREEMENT FOR BUSINESS COMBINATION,VISIOX BECOMING PUBLICLY TRADED COMPANY ON NASDAQ CAPITAL MARKET
* POWERUP ACQUISITION CORP: UPON CLOSING OF TRANSACTION, VISIOX WILL CONTINUE TO BE LED BY CURRENT CEO, RYAN BLEEKS
* POWERUP ACQUISITION CORP - BUSINESS COMBINATION IS EXPECTED TO CLOSE IN Q1 OF 2024
* POWERUP ACQUISITION: UPON CLOSING, COMBINED CO TO BE NAMED VISIOX HOLDINGS, INC. WITH COMMON STOCK EXPECTED TO BE LISTED ON NASDAQ UNDER TICKER VSXP Source text for Eikon: その上の company ニュース報道:
